- Home
- LSPD vs ACAD Comparison
LSPD vs ACAD Comparison
Compare LSPD & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSPD
- ACAD
- Stock Information
- Founded
- LSPD 2005
- ACAD 1993
- Country
- LSPD Canada
- ACAD United States
- Employees
- LSPD N/A
- ACAD N/A
- Industry
- LSPD
- ACAD Biotechnology: Pharmaceutical Preparations
- Sector
- LSPD
- ACAD Health Care
- Exchange
- LSPD Nasdaq
- ACAD Nasdaq
- Market Cap
- LSPD 2.7B
- ACAD 2.6B
- IPO Year
- LSPD 2020
- ACAD 2004
- Fundamental
- Price
- LSPD $17.28
- ACAD $16.77
- Analyst Decision
- LSPD Buy
- ACAD Buy
- Analyst Count
- LSPD 14
- ACAD 19
- Target Price
- LSPD $18.68
- ACAD $26.44
- AVG Volume (30 Days)
- LSPD 1.0M
- ACAD 1.4M
- Earning Date
- LSPD 11-07-2024
- ACAD 11-06-2024
- Dividend Yield
- LSPD N/A
- ACAD N/A
- EPS Growth
- LSPD N/A
- ACAD N/A
- EPS
- LSPD N/A
- ACAD 0.78
- Revenue
- LSPD $1,013,184,000.00
- ACAD $929,236,000.00
- Revenue This Year
- LSPD $23.40
- ACAD $35.78
- Revenue Next Year
- LSPD $18.81
- ACAD $8.58
- P/E Ratio
- LSPD N/A
- ACAD $21.60
- Revenue Growth
- LSPD 24.73
- ACAD 47.06
- 52 Week Low
- LSPD $11.01
- ACAD $14.15
- 52 Week High
- LSPD $21.71
- ACAD $32.59
- Technical
- Relative Strength Index (RSI)
- LSPD 62.66
- ACAD 58.08
- Support Level
- LSPD $16.62
- ACAD $14.41
- Resistance Level
- LSPD $18.88
- ACAD $18.71
- Average True Range (ATR)
- LSPD 0.60
- ACAD 0.67
- MACD
- LSPD 0.20
- ACAD 0.22
- Stochastic Oscillator
- LSPD 61.14
- ACAD 54.88
About LSPD Lightspeed Commerce Inc. Subordinate Voting Shares
Lightspeed Commerce Inc provides an omni-channel commerce-enabling SaaS platform. Its software platform provides customers with the functionality it needs to engage with consumers, manage their operations, accept payments, and grow their businesses. The company sells its platform through a direct sales force in the United States, Canada, New Zealand, United Kingdom, Australia, Germany, and other countries. It derives a majority of its revenue from the United States.
About ACAD ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.